Extent of Virulence and Antibiotic Resistance Genes in Helicobacter pylori and Campylobacteria
- PMID: 38652129
- DOI: 10.1007/s00284-024-03653-5
Extent of Virulence and Antibiotic Resistance Genes in Helicobacter pylori and Campylobacteria
Abstract
Helicobacter pylori, a member of the clade campylobacteria, is the leading cause of chronic gastritis and gastric cancer. Virulence and antibiotic resistance of H. pylori are of great concern to public health. However, the relationship between virulence and antibiotic resistance genes in H. pylori in relation to other campylobacteria remains unclear. Using the virulence and comprehensive antibiotic resistance databases, we explored all available 354 complete genomes of H. pylori and compared it with 90 species of campylobacteria for virulence and antibiotic resistance genes/proteins. On average, H. pylori had 129 virulence genes, highest among Helicobacter spp. and 71 antibiotic resistance genes, one of the lowest among campylobacteria. Just 2.6% of virulence genes were shared by all campylobacterial members, whereas 9.4% were unique to H. pylori. The cytotoxin-associated genes (cags) seemed to be exclusive to H. pylori. Majority of the isolates from Asia and South America were cag2-negative and many antibiotic resistance genes showed isolate-specific patterns of occurrence. Just 15 (8.8%) antibiotic resistance genes, but 103 (66%) virulence genes including 25 cags were proteomically identified in H. pylori. Arcobacterial members showed large variation in the number of antibiotic resistance genes and there was a positive relation with the genome size. Large repository of antibiotic resistance genes in campylobacteria and a unique set of virulence genes might have important implications in shaping the course of virulence and antibiotic resistance in H. pylori.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Hooi JKY, Lai WY, Ng WK et al (2017) Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterol 153:P420–P429. https://doi.org/10.1053/j.gastro.2017.04.022 - DOI
-
- Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347:1175–1186. https://doi.org/10.1056/NEJMra020542 - DOI - PubMed
-
- Etemadi A, Safiri S, Sepanlou SG et al (2020) The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol 5:42–54. https://doi.org/10.1016/S2468-1253(19)30328-0 - DOI
-
- Chiang T-H, Chang W-J, Chen SL-S et al (2021) Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands. Gut 70:243–250. https://doi.org/10.1136/gutjnl-2020-322200 - DOI - PubMed
-
- Choi IJ, Kim CG, Lee JY et al (2020) Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med 382:427–436. https://doi.org/10.1056/NEJMoa1909666 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
